SCHEMBL13764885

SCHEMBL13764885

COc1ccc(C(Nc2ccc(CN[Si](C)(C)C(C)(C)C)cc2)[C@@H](CC[C@H](O[Si](C)(C)C(C)(C)C)c2ccc(F)cc2)C(=O)O[Si](C)(C)C(C)(C)C)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.36
KMT2A Q03164 6/20 0.36
POLB P06746 3/20 0.36
MAPK1 P28482 2/20 0.36
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
LMNA P02545 4/20 0.35
HTT P42858 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
MITF O75030 1/20 0.35
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
GPR35 Q9HC97 1/20 0.35
GPR55 Q9Y2T6 1/20 0.35
XBP1 P17861 1/20 0.35
GAA P10253 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 1/20 0.34
KLK7 P49862 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3998793 1.00 MEN1 (0.36) MEN1KMT2APOLBMAPK1MAPT
SCHEMBL3998788 1.00 MEN1 (0.36) MEN1KMT2APOLBMAPK1MAPT
SCHEMBL3998019 0.85 KMT2A (0.38) MEN1KMT2APOLBMAPK1MAPT
SCHEMBL3998015 0.85 KMT2A (0.38) MEN1KMT2APOLBMAPK1MAPT
SCHEMBL13764887 0.82 LMNA (0.39) MEN1KMT2APOLBMAPK1MAPT
SCHEMBL4005388 0.82 LMNA (0.39) MEN1KMT2APOLBMAPK1MAPT
SCHEMBL4005382 0.82 LMNA (0.39) MEN1KMT2APOLBMAPK1MAPT
SCHEMBL4299266 0.80 KMT2A (0.35) MEN1KMT2APOLBMAPK1MAPT
SCHEMBL4299268 0.80 KMT2A (0.35) MEN1KMT2APOLBMAPK1MAPT
SCHEMBL4299269 0.80 KMT2A (0.35) MEN1KMT2APOLBMAPK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7563888-B2 Process for the preparation of diphenyl azetidinone derivatives SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2009-07-21 US disclosed
US-20070149501-A1 PROCESS FOR THE PREPARATION OF DIPHENYL AZETIDINONE DERIVATIVES SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2007-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149501-A1 PROCESS FOR THE PREPARATION OF DIPHENYL AZETIDINONE DERIVATIVES CYP46A1, APOB, DHCR7 MEN1 1200/4885KMT2A 1869/4885POLB 2896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.